Literature DB >> 31128614

Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.

Koji Furuuchi1, Kozo Morimoto2, Takashi Yoshiyama1, Yoshiaki Tanaka1, Keiji Fujiwara1, Masao Okumura1, Kiyohiko Izumi3, Yuji Shiraishi1, Satoshi Mitarai4, Hideo Ogata1, Atsuyuki Kurashima1, Kozo Yoshimori1, Ken Ohta1, Hajime Goto1, Yuka Sasaki1.   

Abstract

BACKGROUND AND OBJECTIVES: The incidence of nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing, while that of tuberculosis (TB) is decreasing in many industrialized countries, including Japan. However, the long-term evaluation of clinico-epidemiological features of NTM-PD in relation to TB are limited. We aimed to clarify the long-term changes in the epidemiology and clinical features of NTM-PD in relation to those of TB at a nationally-designated TB center in Japan.
METHODS: We reviewed all mycobacterial examination records at Fukujuji Hospital between 2006 and 2016. Cases of NTM-PD were defined according to the 2007 American Thoracic Society/Infectious Disease Society of America microbiologic criteria. The current characteristics of Mycobacterium avium complex pulmonary disease (MAC-PD) were compared with those in the 1980s and circa 2000.
RESULTS: We identified a total of 3,546 pulmonary TB cases and 2,155 NTM-PD cases. While the annual number of incident pulmonary TB cases remained stable over the study period (P = 0.59), that of NTM-PD cases increased significantly from 165 to 278 (P < 0.01). The mean age of pulmonary TB cases increased from 59.7 ± 16.3 to 66.2 ± 21.7 years, whereas that of NTM-PD cases remained unchanged. Regarding the age distribution, the greatest increases were observed in patients over 75 years for TB and in patients 50-74 years for NTM. The most common causative organism for NTM was Mycobacterium avium complex (87.3%), M. abscessus complex (5.5%) and M. kansasii (3.9%). Among patients with MAC-PD, the proportion of the nodular bronchiectatic (NB) form increased significantly from 60.0% to 84.4% between circa 2000 and 2016 (P < 0.01). Significant increases in the NB form were observed in both males (33.3%-70.7%, P < 0.01) and females (71.3%-89.2%, P < 0.01).
CONCLUSIONS: The annual number of incident NTM-PD cases increased markedly. In contrast to patients with TB, the mean age of new NTM-PD patients did not increase in the last 10 years. Among MAC-PD patients, the proportions accounted for by the NB form increased significantly in both sexes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical features; Epidemiology; Japan; Nontuberculous mycobacteria; Tuberculosis

Mesh:

Year:  2019        PMID: 31128614     DOI: 10.1016/j.rmed.2019.05.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Novel Screening System of Virulent Strains for the Establishment of a Mycobacterium avium Complex Lung Disease Mouse Model Using Whole-Genome Sequencing.

Authors:  Koji Furuuchi; Shintaro Seto; Hajime Nakamura; Haruka Hikichi; Akiko Miyabayashi; Keiko Wakabayashi; Kazue Mizuno; Teruaki Oka; Kozo Morimoto; Minako Hijikata; Naoto Keicho
Journal:  Microbiol Spectr       Date:  2022-05-17

2.  Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study.

Authors:  Hiromu Tanaka; Takanori Asakura; Shoji Suzuki; Satoshi Okamori; Tatsuya Kusumoto; Takunori Ogawa; Shunsuke Uno; Atsuho Morita; Ho Lee; Ho Namkoong; Hirofumi Kamata; Yasunori Sato; Yoshifumi Uwamino; Tomoyasu Nishimura; Makoto Ishii; Koichi Fukunaga; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2022-05-21       Impact factor: 3.320

3.  Clinical Characteristics and Mortality of Non-tuberculous Mycobacterial Infection in Immunocompromised vs. Immunocompetent Hosts.

Authors:  Jingjing Chai; Xu Han; Qimin Mei; Tao Liu; Joseph Harold Walline; Jia Xu; Yecheng Liu; Huadong Zhu
Journal:  Front Med (Lausanne)       Date:  2022-05-18

4.  Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.

Authors:  Shunsuke Mori; Yukinori Koga; Kazuyoshi Nakamura; Sayuri Hirooka; Takako Matsuoka; Hideshi Uramoto; Osamu Sakamoto; Yukitaka Ueki
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

Review 5.  Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.

Authors:  Pakpoom Phoompoung; Methee Chayakulkeeree
Journal:  J Fungi (Basel)       Date:  2020-12-08

6.  Non-tuberculous Mycobacterial Infection of the Musculoskeletal System Detected at Two Tertiary Medical Centres in Henan, China, 2016-2020.

Authors:  Qiong Ma; Rende Chen; Enhui Yang; Youhua Yuan; Yongfu Tian; Yongguang Han; Shanmei Wang; Baoya Wang; Wenjuan Yan; Qi Zhang; Nan Jing; Bing Ma; Zhen Wang; Yi Li; Yongjun Li
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

7.  Prevalence of Latent Tuberculous Infection in Patients With Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country.

Authors:  Ho-Sheng Lee; Yu-Feng Wei; Yi-Jung Tsai; Ping-Huai Wang; Chung-Yu Chen; Sheng-Wei Pan; Chin-Chung Shu
Journal:  Open Forum Infect Dis       Date:  2022-02-09       Impact factor: 3.835

8.  Risk Factors and Mental Health Status in Patients With Non-Tuberculous Mycobacterial Lung Disease: A Single Center Retrospective Study.

Authors:  Zhangyan Zhao; Huiliang Hu; Mei Wang; Feng Li; Haicheng Tang
Journal:  Front Public Health       Date:  2022-08-01

9.  Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.

Authors:  Ryoji Maekura; Keisuke Miki; Yoshitaka Tateishi; Sohkichi Matsumoto; Seigo Kitada; Mari Miki; Hiroshi Kida
Journal:  Microbiol Spectr       Date:  2022-04-25

10.  Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.

Authors:  Christina M Mingora; Bryan A Garcia; Kevin C Mange; Dayton W Yuen; Monika Ciesielska; Jakko van Ingen; Patrick A Flume; Susan E Dorman
Journal:  BMC Infect Dis       Date:  2022-03-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.